Seth Harmon
Director of Finance/CFO at VIRIDIAN THERAPEUTICS, INC.
Net worth: 12 700 $ as of 2024-04-29
Seth Harmon active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2023-09-11 | - |
| Director of Finance/CFO | 2023-09-11 | - | |
| Corporate Officer/Principal | 2023-04-30 | 2023-09-11 |
Career history of Seth Harmon
Former positions of Seth Harmon
| Companies | Position | Start | End |
|---|---|---|---|
| BIONTECH SE | Director of Finance/CFO | 2020-04-30 | 2023-04-30 |
| NEON THERAPEUTICS, INC. | Corporate Officer/Principal | 2017-03-31 | 2020-04-30 |
Training of Seth Harmon
| Northeastern University | Graduate Degree |
| Bowdoin College | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Germany | 2 |
Operational
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| BIONTECH SE | Health Technology |
| Private companies | 1 |
|---|---|
BioNTech US, Inc.
 BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Seth Harmon
- Experience
